BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20045784)

  • 1. Molecular mechanisms behind the resistance of cisplatin in germ cell tumours.
    Piulats JM; Jiménez L; García del Muro X; Villanueva A; Viñals F; Germà-Lluch JR
    Clin Transl Oncol; 2009 Dec; 11(12):780-6. PubMed ID: 20045784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
    Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
    BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
    Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
    J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
    Ottaviano M; Giunta EF; Rescigno P; Pereira Mestre R; Marandino L; Tortora M; Riccio V; Parola S; Casula M; Paliogiannis P; Cossu A; Vogl UM; Bosso D; Rosanova M; Mazzola B; Daniele B; Palmieri G; Palmieri G
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
    Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of
    Timmerman DM; Eleveld TF; Gillis AJM; Friedrichs CC; Hillenius S; Remmers TL; Sriram S; Looijenga LHJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
    Lobo J; Constâncio V; Leite-Silva P; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
    Clin Epigenetics; 2021 Apr; 13(1):70. PubMed ID: 33823933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The component of the m
    Miranda-Gonçalves V; Lobo J; Guimarães-Teixeira C; Barros-Silva D; Guimarães R; Cantante M; Braga I; Maurício J; Oing C; Honecker F; Nettersheim D; Looijenga LHJ; Henrique R; Jerónimo C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):268. PubMed ID: 34446080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
    Schmidtova S; Kalavska K; Kucerova L
    Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.
    Bagrodia A; Lee BH; Lee W; Cha EK; Sfakianos JP; Iyer G; Pietzak EJ; Gao SP; Zabor EC; Ostrovnaya I; Kaffenberger SD; Syed A; Arcila ME; Chaganti RS; Kundra R; Eng J; Hreiki J; Vacic V; Arora K; Oschwald DM; Berger MF; Bajorin DF; Bains MS; Schultz N; Reuter VE; Sheinfeld J; Bosl GJ; Al-Ahmadie HA; Solit DB; Feldman DR
    J Clin Oncol; 2016 Nov; 34(33):4000-4007. PubMed ID: 27646943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular bases of platinum-resistance in testicular cancer].
    Germà-Lluch JR; Piulats JM
    Arch Esp Urol; 2013 Jun; 66(5):524-35. PubMed ID: 23793770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.
    Kalavska K; Conteduca V; De Giorgi U; Mego M
    Curr Cancer Drug Targets; 2018; 18(10):967-978. PubMed ID: 29295694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
    Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
    Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
    Schmidtova S; Kalavska K; Liskova V; Plava J; Miklikova S; Kucerova L; Matuskova M; Rojikova L; Cierna Z; Rogozea A; Konig H; Albany C; Mego M; Chovanec M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
    Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
    Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours.
    Harpelunde Poulsen K; Nielsen JE; Grønkær Toft B; Joensen UN; Rasmussen LJ; Blomberg Jensen M; Mitchell RT; Juul A; Rajpert-De Meyts E; Jørgensen A
    BMC Cancer; 2020 Apr; 20(1):349. PubMed ID: 32326899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.
    Noel EE; Yeste-Velasco M; Mao X; Perry J; Kudahetti SC; Li NF; Sharp S; Chaplin T; Xue L; McIntyre A; Shan L; Powles T; Oliver RT; Young BD; Shipley J; Berney DM; Joel SP; Lu YJ
    Am J Pathol; 2010 Jun; 176(6):2607-15. PubMed ID: 20395447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.